Rex MD Semaglutide Pricing — 2026 Pricing, Plans, and Verdict

Last reviewed: September 19, 2026 Last updated: September 19, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Rex MD publishes $349 per month for oral semaglutide (branded Wegovy pill) and $499 per month for injectable semaglutide (Wegovy pen), both described as ongoing monthly rates with no documented first-month discount or separate refill pricing tier (rexmd.com/weight-management, rexmd.com/our-medications/weight-management/semaglutide; captured September 4, 2026). The platform uses monthly billing with no membership fee; the figures are presented as "starting" prices that apply across titration doses, meaning dose increases during the titration phase do not change the monthly cost. Over twelve months, the oral program totals $4,188 and the injectable program totals $5,988 (our calculation). Both products are FDA-approved brand Wegovy, not compounded formulations. For comparison, PlexusDx offers compounded semaglutide injection at $189 per month month-to-month ($2,268 over twelve months; our calculation), $2,028 per year on a three-month commitment ($169/month prepaid quarterly; our calculation), or $1,788 per year on a six-month commitment ($149/month prepaid semi-annually; our calculation)—a difference of $1,920 to $3,720 annually when comparing like-for-like injectable routes (our calculation). The Rex MD pricing structure is straightforward—one published rate, no tiers—but the evidence is "primary-partial": the figures come from live public pages that timed out during deeper verification, and no account or payment was submitted to confirm checkout-level details or the presence of any separate program fees for the injectable pen.

At-a-glance: Rex MD vs PlexusDx semaglutide pricing

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Rex MD pricing structure: no first-month discount found

The assigned topic asks for first-month versus refill pricing analysis, but the September 4, 2026 capture of Rex MD's weight-management and semaglutide product pages shows flat monthly rates with no documented introductory period or refill tier. The oral Wegovy pill is advertised at "$349/mo including medication and provider care," described as a "starting price" that is "locked across titration doses"; the injectable Wegovy pen shows a "$499/month medication cash price…regardless of dosage strength for eligible self-pay patients" (rexmd.com/weight-management, rexmd.com/our-medications/weight-management/semaglutide; captured September 4, 2026). The term "starting" in Rex MD's phrasing relates to dose-path eligibility—not every patient qualifies for every formulation, and a clinician determines the appropriate starting dose—but the captured evidence does not show a lower first-month rate followed by a higher refill rate. Both products bill monthly with one-month supplies, and no membership or service fee is documented for the oral program; the injectable pen page shows $0 for membership/service monthly fee but includes the caveat "Confirm whether any separate program fee applies," indicating incomplete verification at checkout (rexmd.com/our-medications/weight-management/semaglutide; captured September 4, 2026). The evidence status is "Primary-partial"—the figures come from live indexed pages that timed out during deeper research, and no account or payment was submitted to test the full checkout flow.

In short, the cleanest read of the available evidence is that Rex MD charges $349 every month for the oral pill and $499 every month for the injectable pen, with the same rate applying from the first month through refills and dose titration. If you encounter a different figure at checkout, or if Rex MD introduces a first-month promotion after September 4, 2026, the published price has changed; confirm the current rate and any program-fee line items before committing.

Normalized 12-month cost comparison

To understand what a year of treatment costs when prices are flat and monthly, the calculation is straightforward: multiply the monthly rate by twelve.

Rex MD oral semaglutide (Wegovy pill)

• Monthly rate: $349
• 12-month total: $349 × 12 = $4,188 (our calculation)
• Effective monthly cost over 12 months: $349 (no prepayment, no discount)

Rex MD injectable semaglutide (Wegovy pen)

• Monthly rate: $499
• 12-month total: $499 × 12 = $5,988 (our calculation)
• Effective monthly cost over 12 months: $499 (no prepayment, no discount)

PlexusDx compounded semaglutide injection

• Month-to-month: $189/month → $189 × 12 = $2,268 annually (our calculation)
• 3-month commitment: $169/month prepaid quarterly → $169 × 12 = $2,028 annually (our calculation; labeled as prepaid)
• 6-month commitment: $149/month prepaid semi-annually → $149 × 12 = $1,788 annually (our calculation; labeled as prepaid)

Cost difference (injectable route, month-to-month)

• Rex MD pen vs PlexusDx injection (MTM): $499 – $189 = $310 more per month for Rex MD (our calculation)
• 12-month difference: $5,988 – $2,268 = $3,720 more for Rex MD over one year (our calculation)

Cost difference (oral Rex MD vs injectable PlexusDx, month-to-month)

• Rex MD oral pill vs PlexusDx injection (MTM): $349 – $189 = $160 more per month for Rex MD oral (our calculation)
• 12-month difference: $4,188 – $2,268 = $1,920 more for Rex MD oral over one year (our calculation)

Every price above carries its source and capture date; the Rex MD figures come from rexmd.com pages captured September 4, 2026, and the PlexusDx figures come from the alternatives page captured July 17–23, 2026. The 12-month totals and cost differences are our calculations, derived by multiplying or subtracting the published monthly rates. If you see conflicting numbers at checkout, confirm the current pricing with the provider before purchase.

What the price includes

Rex MD's oral Wegovy pill at $349/month is described as including "medication and provider care," and the injectable pen at $499/month is listed as the "medication cash price" via the NovoCare pathway (rexmd.com/weight-management, rexmd.com/our-medications/weight-management/semaglutide; captured September 4, 2026). Both products are FDA-approved brand Wegovy, not compounded formulations. The oral page shows $0 for membership or service monthly fee; the injectable page also shows $0 but adds the note "Confirm whether any separate program fee applies," signaling that the researcher could not verify the full line-item breakdown at checkout. Neither page documents cancellation or refund policies in the captured September 4, 2026 evidence.

PlexusDx's $189/month compounded semaglutide injection (month-to-month) or $169/month (three-month prepaid) or $149/month (six-month prepaid) includes the online provider visit, prescription, compounded medication, and shipping in one flat price with no membership fee, no visit charges, and no surcharge for dose increases during titration. Compounded semaglutide is not FDA-approved and is not interchangeable with branded Wegovy; a licensed clinician determines whether a compounded prescription is appropriate for an individual patient, and PlexusDx works with licensed 503A compounding pharmacies.

Branded Wegovy vs compounded semaglutide

The central trade-off in this comparison is FDA-approved brand medication at a higher monthly cost versus compounded semaglutide at a significantly lower cost. Branded Wegovy (whether oral pill or injectable pen) has passed FDA review for safety, effectiveness, and manufacturing quality, and every dose is produced under the oversight that approval entails. Compounded medications are prepared by a licensed pharmacy to a clinician's prescription but are not FDA-approved; FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. For many patients, the cost difference—$1,920 to $3,720 annually in this comparison—justifies accepting a compounded formulation, especially when the active ingredient (semaglutide) is the same molecule and the compounding pharmacy is licensed and inspected. For others, the FDA approval and brand-manufacturer accountability justify the higher cost. Neither choice is universally "better"; the decision depends on your budget, your comfort with compounded versus branded medications, and your clinician's assessment of what is appropriate for you.

Strengths and gaps in the Rex MD offering

Strengths

• FDA-approved brand medication: Both the oral pill and injectable pen are Wegovy, which has completed FDA review for weight management.
• Locked rate across titration: The published price does not increase when your dose is titrated upward during the maintenance phase.
• No documented membership fee for the oral program, and $0 shown (with caveat) for the injectable pen.
• Oral option available: The $349/month Wegovy pill offers an alternative route for patients who prefer to avoid injections.

Gaps and uncertainties

• Incomplete checkout verification: The evidence is "Primary-partial"—live pages timed out, no account was created, and no payment was submitted. The $349 and $499 figures are from indexed public pages captured September 4, 2026, and the injectable pen page includes the advisory "Confirm whether any separate program fee applies."
• No cancellation or refund policy documented in the captured evidence; confirm those terms directly with Rex MD before committing.
• High absolute cost: Even the lower-priced oral option ($4,188 annually) is nearly double PlexusDx's month-to-month compounded injectable rate ($2,268 annually; our calculations).
• Limited review data: A Trustpilot profile exists at trustpilot.com/review/rexmd.com (captured September 4, 2026), but no rating, review volume, or thematic analysis was captured in this research pass; we cannot compare service quality or reliability against PlexusDx's 4.3-star Trustpilot rating (79% five-star, 83% four stars or higher; trustpilot.com/review/plexusdx.com; captured September 9, 2026).
• "Starting price" ambiguity: The term "starting" is used alongside "locked across titration doses," which together suggest the rate applies throughout treatment, but the phrasing leaves room for interpretation; confirm that the quoted price applies to your specific dose and clinical path.

Choose Rex MD if…

• You want FDA-approved brand Wegovy and are willing to pay a premium for that approval and manufacturing oversight.
• You prefer an oral pill formulation and the $349/month cost fits your budget.
• You value a platform that locks the monthly rate across dose titration, so your cost does not climb as your maintenance dose increases.
• You are comfortable with month-to-month billing and do not need or want a multi-month commitment discount.

Where PlexusDx compounded semaglutide fits

• You want the lowest absolute cost for semaglutide treatment—$189/month month-to-month ($2,268 annually), $169/month on a three-month commitment ($2,028 annually), or $149/month on a six-month commitment ($1,788 annually; all figures are our calculations).
• You are comfortable with compounded (not FDA-approved) medication prepared by a licensed 503A compounding pharmacy, and a licensed clinician has determined it is appropriate for you.
• You want one flat published price with no membership fees, no visit charges, and no dose-increase surcharges—provider visit, prescription, medication, and shipping included.
• You value transparent service-quality data: PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (trustpilot.com/review/plexusdx.com; captured September 9, 2026).
• You want the flexibility to cancel month-to-month or lock a lower rate with a three- or six-month prepaid commitment.

Methodology and freshness

Rex MD pricing data (oral $349/month, injectable $499/month) was captured September 4, 2026 from rexmd.com/weight-management and rexmd.com/our-medications/weight-management/semaglutide. The evidence status is "Primary-partial": the figures come from live indexed pages that timed out during deeper verification, and no account or payment was submitted to confirm checkout-level details. The injectable pen page includes the note "Confirm whether any separate program fee applies," reflecting incomplete verification. PlexusDx pricing ($189 MTM, $169 three-month, $149 six-month for compounded semaglutide injection) was captured July 17–23, 2026 from the alternatives page. PlexusDx review data (4.3-star Trustpilot, 79% five-star) was verified September 9, 2026 at trustpilot.com/review/plexusdx.com. All 12-month totals and cost differences are our calculations, derived by multiplying or subtracting the published monthly rates. Rex MD review data was checked (Trustpilot profile exists at trustpilot.com/review/rexmd.com, captured September 4, 2026) but no rating, volume, or themes were captured in this pass. No first-month or refill price distinction was found for Rex MD; the $349 and $499 figures are presented as flat ongoing monthly rates. If you encounter different pricing at checkout, the published rates have changed; confirm current figures and all line items before purchase.

Frequently Asked Questions

Does Rex MD charge less for the first month than for refills?

No documented first-month discount or separate refill pricing tier was found in the September 4, 2026 capture of Rex MD's weight-management and semaglutide product pages. The oral Wegovy pill is listed at $349/month and the injectable pen at $499/month, both described as flat ongoing rates that are "locked across titration doses." If Rex MD introduces a promotional first-month rate after that date, confirm the offer details and refill cost directly with the provider.

Is Rex MD's semaglutide the same as PlexusDx's semaglutide?

No. Rex MD offers FDA-approved brand Wegovy (both oral pill and injectable pen), which has passed FDA review for safety, effectiveness, and quality. PlexusDx offers compounded semaglutide injection, which is not FDA-approved; FDA does not review compounded drugs before marketing. The active ingredient—semaglutide—is the same molecule, but the regulatory pathway, manufacturing oversight, and price differ. A licensed clinician determines whether a compounded prescription is appropriate for you.

How much do I save over a year by choosing PlexusDx compounded semaglutide instead of Rex MD?

Comparing month-to-month injectable programs, Rex MD's Wegovy pen at $499/month totals $5,988 over twelve months, and PlexusDx compounded semaglutide injection at $189/month totals $2,268 over twelve months—a difference of $3,720 annually (our calculations). If you compare Rex MD's oral Wegovy pill ($349/month, $4,188 annually) to PlexusDx injection, the difference is $1,920 over one year (our calculations). PlexusDx also offers three-month ($2,028 annually) and six-month ($1,788 annually) prepaid options that widen the gap further.

Does Rex MD charge a membership or program fee on top of the medication price?

The oral Wegovy pill page shows $0 membership or service monthly fee. The injectable Wegovy pen page also shows $0 but includes the caveat "Confirm whether any separate program fee applies" (rexmd.com/our-medications/weight-management/semaglutide; captured September 4, 2026). The evidence is "Primary-partial"—no checkout was completed—so confirm the full line-item breakdown before purchase. PlexusDx charges no membership, visit, or program fees; the published monthly price includes provider visit, prescription, medication, and shipping.

What happens if I need a dose increase—does the monthly price go up?

Rex MD's pages state that the $349 oral and $499 injectable rates are "locked across titration doses," meaning dose increases during the maintenance phase do not change the monthly cost (rexmd.com/weight-management, rexmd.com/our-medications/weight-management/semaglutide; captured September 4, 2026). PlexusDx also charges the same flat rate at every semaglutide injection dose—$189 month-to-month, $169 three-month, or $149 six-month—with no surcharge for titration or maintenance-dose increases.

Sources

• Rex MD weight management page: rexmd.com/weight-management (accessed September 4, 2026)
• Rex MD semaglutide product page: rexmd.com/our-medications/weight-management/semaglutide (accessed September 4, 2026)
• PlexusDx alternatives page (accessed July 17–23, 2026)
• PlexusDx Trustpilot profile: trustpilot.com/review/plexusdx.com (accessed September 9, 2026)
• Rex MD Trustpilot profile: trustpilot.com/review/rexmd.com (accessed September 4, 2026)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.